Inicio › Leucemia linfoblástica aguda › Tennessee
Ensayos clínicos de Leucemia linfoblástica aguda en Tennessee
22 estudios sobre Leucemia linfoblástica aguda buscan participantes en Tennessee.
Ciudades en Tennessee
Texto oficial del estudio (inglés)
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- TriStar Bone Marrow Transplant / Sarah Cannon Transplant & Cellular Therapy, Nashville
ReclutandoFase 2
6 Months · Todos los sexos · Actualizado el 28 sept 2026 · NCT06514794Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
- St. Jude Children's Research Hospital, Memphis
ReclutandoSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT06819475Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
- St. Jude Children's Research Hospital, Memphis
ReclutandoFase 1
Hasta los 21 · Todos los sexos · Actualizado el 31 ago 2026 · NCT04881240CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
- St. Jude Children's Research Hospital, Memphis
ReclutandoFase 1
Hasta los 21 · Todos los sexos · Actualizado el 28 ago 2026 · NCT07257419The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- East Tennessee Childrens Hospital, Knoxville
- Saint Jude Children's Research Hospital, Memphis
- The Children's Hospital at TriStar Centennial, Nashville
- y 1 más
ReclutandoFase 1/2
Hasta los 22 · Todos los sexos · Actualizado el 25 ago 2026 · NCT04726241A Study of CTD402 in T-ALL/LBL Patients
- Sarah Cannon Research Insitute, Nashville
ReclutandoFase 1/2
Edades de 1 en adelante · Todos los sexos · Actualizado el 19 ago 2026 · NCT07070219Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
- St. Jude Children's Research Hospital, Memphis
Reclutando
Edades de 20 a 50 · Todos los sexos · Actualizado el 14 ago 2026 · NCT07191119Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
- Vanderbilt University Medical Center, Nashville
ReclutandoEstudio observacional
1 Day – 17 Years · Todos los sexos · Actualizado el 14 ago 2026 · NCT06274788Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
- St. Jude Children's Research Hospital, Memphis
ReclutandoFase 2
Edades de 1 a 18 · Todos los sexos · Actualizado el 16 jul 2026 · NCT06533748Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma
- St. Jude Children's Research Hospital, Memphis
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 jul 2026 · NCT06747910Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
- St. Jude Children's Research Hospital, Memphis
ReclutandoFase 4
Edades de 1 a 18 · Todos los sexos · Actualizado el 14 jul 2026 · NCT06289673Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
- Research Site, Franklin
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 13 jul 2026 · NCT07109219A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- St. Jude Childrens Research Hospital, Memphis
- Vanderbilt University, Nashville
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 6 jul 2026 · NCT01351545Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
- St. Jude Children's Research Hospital, Memphis
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 jun 2026 · NCT07228741Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
- St. Jude Children's Research Hospital, Memphis
ReclutandoFase 1/2
Hasta los 21 · Todos los sexos · Actualizado el 3 jun 2026 · NCT04195347CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia
- St. Jude Children's Research Hospital, Memphis
ReclutandoFase 1
Hasta los 21 · Todos los sexos · Actualizado el 19 may 2026 · NCT06777979CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia
- St. Jude Children's Research Hospital, Memphis
ReclutandoFase 2
Hasta los 21 · Todos los sexos · Actualizado el 25 mar 2026 · NCT06847269A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- TriStar Centennial Medical Center, Nashville
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 24 mar 2026 · NCT04988555CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
- St. Jude Children's Research Hospital, Memphis
ReclutandoFase 1
Hasta los 21 · Todos los sexos · Actualizado el 23 ene 2026 · NCT06326463Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
- St. Jude Children's Research Hospital, Memphis
ReclutandoFase 2
Edades de 10 a 30 · Todos los sexos · Actualizado el 4 dic 2025 · NCT05194397HPC Offered for PRESERVE Expansion
- Tristar Centennial Medical Center, Nashville
ReclutandoEstudio observacional
Edades de 12 a 80 · Todos los sexos · Actualizado el 28 ago 2025 · NCT07145411Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- St. Jude Children's Research Hospital, Memphis
ReclutandoFase 1
Edades de 1 a 21 · Todos los sexos · Actualizado el 6 dic 2024 · NCT05476770De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.